2021 annual financial data
Gain Therapeutics, Inc. 2021 Operating margin
Gain Therapeutics, Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was -8,379.8%.
Operating income was -13,826,173 USD and net income was -13,890,606 USD.
Operating cash flow was -12,365,670 USD.
Get free Gain Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 164,994 USD
- Operating income
- -13,826,173 USD
- Net income
- -13,890,606 USD
- Operating cash flow
- -12,365,670 USD